A phase III comparison of radiation therapy with or without recombinant β-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04)-Reference-Cited by-同舟云学术

A phase III comparison of radiation therapy with or without recombinant β-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04)

Published:2002-04 Issue:5 Volume:52 Page:1173-1179
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bradley Jeffrey D,Scott Charles B,Paris Kristie J,Demas William F,Machtay Mitchell,Komaki Ritsuko,Movsas Benjamin,Rubin Philip,Sause William T

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Cancer statistics 2001;Greenlee;Cancer Stat,2001

2. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage III non-small cell lung cancer;Dillman;N Engl J Med,1990

3. Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small cell lung cancer treated with radiation therapy;Curran;J Clin Oncol,1990

4. Combined Betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer;McDonald;Int J Radiat Oncol Biol Phys,1993

5. Proceedings of the American Society of Clinical Oncology - Abstract #1891;Curran,2000

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type I interferon signaling promotes radioresistance in head and neck cancer;Translational Cancer Research;2024-05

2. Nuclear Medicine in the Assessment of Adverse Effects of Cancer Therapy in the Lung, Kidney, Gastrointestinal Tract, and Central Nervous System;Nuclear Oncology;2022

3. Nuclear Medicine in the Assessment of Adverse Effects of Cancer Therapy in the Lung, Kidney, Gastrointestinal Tract, and Central Nervous System;Nuclear Oncology;2022

4. Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non–Small Cell Lung Cancer and Poor Performance Status;JAMA Oncology;2021-10-01

5. Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy;Cancers;2021-09-26